Special Issue "Advances in Markers of Psychiatric Disorders"
Deadline for manuscript submissions: 31 March 2021.
Interests: Behavioral Pharmacology; Clinical Neurophysiology; Neuropsychopharmacology; Psychopharmacology; Sleep Disorders; Alcohol Addiction; Smoking; Eating Disorders; Glycoconjugates; Epidemiology
Psychiatric disorders (mental illness) constitute a wide group of disorders, including depression, bipolar disorder, schizophrenia and other psychoses, anxiety disorders, substance-related disorders, dementia, and developmental disorders, e.g., autism. They have a specific behavioral and mental pattern, and characterized by a combination of abnormal thoughts, perceptions, emotions, behaviour, and relationships with others. They can be persistent, relapsing/remitting, or can occur as a single episode. Psychiatric disorders significantly worsen the lives of the people suffering from them. Up to one third of world’s population has some kind of a psychiatric disorder in a given year. These disorders affect the entire structure of people's lives, and cause significant distress or impairment of personal functioning, deteriorating quality of life and the course of somatic diseases. The diagnosis of mental disorders at an early stage allows for early treatment and/or psychotherapy, before the maximum severity of symptoms and hospitalization occur. With the current rapid social development and technology, we have many diagnostic options, such as biochemical, neuroimaging, neurophysiological, neurocognitive and the most commonly used: clinical. Biochemical tests are carried out using many body fluids. Currently, salivary diagnostics in psychiatry is increasing, as saliva contains a wide array of compounds which sensitively respond to biochemical changes in the organism, reflecting the real-time level of these markers, and can be taken in a non-invasive way, which reduces the patient’s stress. Biomarkers are tools used to more accurately identify high-risk individuals, speed up diagnosis, and help increase the likelihood of successful treatment and prognosis determination. The goal of this Special Issue is to summarize new advances in the markers of psychiatric disorders, including depression, bipolar disorder, schizophrenia and other psychoses, anxiety disorders, substance-related disorders, dementia, and developmental disorders such as autism. Original research and review articles are both welcome in order to best understand the importance of different markers of psychiatric illness. Potential topics include but are not limited to the following: advances in clinical markers of psychiatric disorders, advances in molecular and biochemical markers of psychiatric disorders, advances in (neuro)imaging markers of psychiatric disorders, advances in neurophysiological markers of psychiatric disorders, advances in neurocognitive markers of psychiatric disorders, and advances in markers of successful treatment in psychiatry.
Prof. Dr. Napoleon Waszkiewicz
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- psychiatric disorders